Universität Freiburg
Welcome,         Profile    Billing    Logout  
 10 Trials 
19 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LAZARO, Estibaliz
BE-EARLY, NCT06411249: A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)

Recruiting
4
350
Europe, Japan, US, RoW
Belimumab (GSK1550188), BEL (BENLYSTA)
GlaxoSmithKline
Systemic Lupus Erythematosus
04/27
05/29
Shingr'HIV, NCT05575830: Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls

Recruiting
4
225
Europe
Recombinant Zoster Vaccine, (Shingrix® )
Calmy Alexandra
RZV Vaccine (Shingrix ®)
09/24
09/25
BIGG, NCT03132116: Intra-nodal Injection of Gentamicin for the Treatment of Suppurated Cat Scratch Disease's Lymphadenitis

Recruiting
3
100
Europe
gentamicin, placebo, NaCl
University Hospital, Toulouse
Cat-Scratch Disease
12/25
12/25
PSSIT, NCT05098704: Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

Recruiting
2/3
90
Europe
clopidogrel treatment, Placebo
University Hospital, Bordeaux, Ministry for Health and Solidarity, France
Scleroderma, Systemic Sclerosis
06/30
06/30
TRIBECA, NCT04629144 / 2020-004519-29: Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)

Recruiting
2
48
Europe
Belimumab, Placebo
Assistance Publique - Hôpitaux de Paris, GSK
Vasculitis, Cryoglobulinemia
04/25
10/25
PREPCOV, NCT04481633: Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection

Recruiting
N/A
800
Europe
COVID 19 serology, COVID 19 Self-Questionnaire
University Hospital, Toulouse
COVID-19
03/22
03/22
ISOLED, NCT03421184: Dietary Phytoestrogens as Risk Factors for Systemic Lupus Erythematosus

Completed
N/A
63
Europe
blood sample, urine sample, food questionnaire, hair
University Hospital, Bordeaux
Lupus Erythematosus, Rheumatoid Arthritis, Autoimmune Thrombocytopenia
06/23
06/23
OPTIMISE, NCT05763225: Validation of Patient E-tool to Measure Systemic Lupus Activity

Completed
N/A
450
Europe, RoW
Association Francaise du Lupus et Autres Maladies Auto-immunes (AFL+), Hometrix Health SAS
Lupus Erythematosus, Systemic
06/24
06/24
METABOLUPS, NCT04440566: O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus

Completed
N/A
50
Europe
blood sample
University Hospital, Bordeaux
Systemic Lupus Erythematosus
02/22
02/22
VASC-FAS, NCT03698071: Soluble CD95 Ligand Role in the Pathophysiology of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitis

Completed
N/A
32
Europe
blood sample, urine sample
University Hospital, Bordeaux, National Research Agency, France
ANCA Associated Vasculitis
05/22
05/22
BIOCAI, NCT04005638: Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia

Recruiting
N/A
200
Europe
blood sample, urine sample
University Hospital, Bordeaux, Ministry for Health and Solidarity, France
Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Autoimmune Neutropenia
01/25
01/25
MARIGYN, NCT05961267: Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism

Completed
N/A
318
Europe
Questionnaire
University Hospital, Bordeaux
Arthritis, Rheumatoid, Spondylitis, Ankylosing, Lupus Erythematosus, Systemic, Scleroderma, Systemic, Sjogren's Syndrome, Mixed Connective Tissue Disease
06/24
06/24
SINGOU, NCT03841318: Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome

Recruiting
N/A
200
Europe
blood sample, biopsy of the labial salivary gland
University Hospital, Bordeaux
Sjogren's Syndrome
08/24
08/24
FerMDS, NCT05924074: Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes

Not yet recruiting
N/A
80
Europe
Biological sampling
University Hospital, Bordeaux
Myelodysplastic Syndromes, Ferroptosis
09/26
09/26
LUPAGE, NCT05698173: Systemic Lupus Erythematosus and Accelerated Aging

Recruiting
N/A
75
Europe
blood sample
University Hospital, Bordeaux, University of Bordeaux, Institut National de la Santé Et de la Recherche Médicale, France
Systemic Lupus Erythematosus
09/25
09/25
ISLE, NCT04276701: Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases

Recruiting
N/A
500
Europe
blood sample, Ultrasonography assessment, questionnaires
University Hospital, Bordeaux, Foundation for Research in Rheumatology (FOREUM)
Systemic Lupus Erythematosus
03/27
03/27
SCLERESO, NCT04265144: Cohort of Patients With Systemic Sclerosis Within the Framework of the RESO Reference Centre

Recruiting
N/A
500
Europe
Blood samples, Biopsy, Bronchoalveolar samples
University Hospital, Bordeaux
Scleroderma, Systemic Sclerosis
06/30
06/30
Voll, Reinhard
NCT04464434 / 2019-004718-32: Upfront Autologous HSCT Versus Immunosuppression in Early Diffuse Cutaneous Systemic Sclerosis

Recruiting
4
50
Europe
Upfront autologous HSCT
UMC Utrecht, ZonMw: The Netherlands Organisation for Health Research and Development, Boehringer Ingelheim, Miltenyi Biotec, Inc.
Systemic Sclerosis, Systemic Scleroses, Diffuse, Scleroderma, Scleroderma, Diffuse, Autologous Stem Cell Transplantation, Cyclophosphamide, Mycophenolate Mofetil, Treatment Strategy
10/27
10/30
ISLE, NCT04276701: Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases

Recruiting
N/A
500
Europe
blood sample, Ultrasonography assessment, questionnaires
University Hospital, Bordeaux, Foundation for Research in Rheumatology (FOREUM)
Systemic Lupus Erythematosus
03/27
03/27

Download Options